Purchase Order 75N91023P00764
Award Date
8/21/23
Potential Completion Date
8/20/24
Potential Value
$24K
Federal Agency
National Cancer Institute
Awardee
Engene Statistics GMBH
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Switzerland
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,407 purchase order to Engene Statistics Sagl of Switzerland for testing services. Under the firm fixed price contract, Engene Statistics Sagl will provide unspecified testing services to the National Cancer Institute from July 31, 2023 through October 31, 2023. The contract was awarded directly to Engene Statistics Sagl as the prime contractor, with no mention of major...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order for $1 million to $5 million to Engene Statistics Sagl of Switzerland for laboratory testing services. Under this contract, Engene Statistics will provide testing support to advance the National Cancer Institute's biomedical research mission. As a small business located in Switzerland, Engene Statistics will leverage their scientific expertise to help...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute to provide testing services in support of biomedical research projects involving high throughput data analysis. With a potential value of $19,123, this purchase order has a completion date of March 14, 2024 and was awarded on November 1, 2023. No major subcontractors or set aside designations were specified. Engene...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, Department of Health and Human Services. The $25,000 purchase order is for testing services to support research efforts through January 31, 2025 with no set aside designation applied. As a privately owned data analytics and statistical consulting company based in Switzerland, Engene Statistics Sagl will...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The $20,000 contract requires Engene to provide laboratory testing services in support of biomedical research projects involving high throughput data analysis. Performance will take place at the National Cancer Institute location in Bethesda, Maryland and...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order contract valued at $25,000 by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The contract is for laboratory testing services to support the research efforts of the National Cancer Institute. Per the award notice, Engene will provide testing services with no subcontractors involved and no set aside...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $12,075.00 firm fixed price purchase order contract to Eurofins Pharma Bioanalytics Services US, LLC, a foreign-owned for-profit organization, for laboratory analysis services. The contract has a period of performance ending on March 19, 2026 and was awarded on March 20, 2025. This contract does not have a set-aside designation.</p>
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>